DE2504994A1 - Verfahren zur kreatininbestimmung - Google Patents
Verfahren zur kreatininbestimmungInfo
- Publication number
- DE2504994A1 DE2504994A1 DE19752504994 DE2504994A DE2504994A1 DE 2504994 A1 DE2504994 A1 DE 2504994A1 DE 19752504994 DE19752504994 DE 19752504994 DE 2504994 A DE2504994 A DE 2504994A DE 2504994 A1 DE2504994 A1 DE 2504994A1
- Authority
- DE
- Germany
- Prior art keywords
- sulfate
- sodium
- detergent
- reagent
- creatinine
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- DDRJAANPRJIHGJ-UHFFFAOYSA-N creatinine Chemical compound CN1CC(=O)NC1=N DDRJAANPRJIHGJ-UHFFFAOYSA-N 0.000 title claims description 64
- 238000000034 method Methods 0.000 title claims description 39
- 229940109239 creatinine Drugs 0.000 title claims description 32
- 239000003153 chemical reaction reagent Substances 0.000 claims description 24
- 239000000243 solution Substances 0.000 claims description 21
- 239000003599 detergent Substances 0.000 claims description 17
- 102000004169 proteins and genes Human genes 0.000 claims description 10
- 108090000623 proteins and genes Proteins 0.000 claims description 10
- XSQUKJJJFZCRTK-UHFFFAOYSA-N Urea Chemical compound NC(N)=O XSQUKJJJFZCRTK-UHFFFAOYSA-N 0.000 claims description 9
- 239000004202 carbamide Substances 0.000 claims description 9
- 229940075930 picrate Drugs 0.000 claims description 9
- OXNIZHLAWKMVMX-UHFFFAOYSA-M picrate anion Chemical compound [O-]C1=C([N+]([O-])=O)C=C([N+]([O-])=O)C=C1[N+]([O-])=O OXNIZHLAWKMVMX-UHFFFAOYSA-M 0.000 claims description 9
- DBMJMQXJHONAFJ-UHFFFAOYSA-M Sodium laurylsulphate Chemical compound [Na+].CCCCCCCCCCCCOS([O-])(=O)=O DBMJMQXJHONAFJ-UHFFFAOYSA-M 0.000 claims description 7
- 238000010521 absorption reaction Methods 0.000 claims description 7
- 239000007788 liquid Substances 0.000 claims description 7
- 239000003513 alkali Substances 0.000 claims description 6
- 238000012360 testing method Methods 0.000 claims description 6
- QAOWNCQODCNURD-UHFFFAOYSA-L Sulfate Chemical compound [O-]S([O-])(=O)=O QAOWNCQODCNURD-UHFFFAOYSA-L 0.000 claims description 5
- DGAQECJNVWCQMB-PUAWFVPOSA-M Ilexoside XXIX Chemical compound C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)OS(=O)(=O)[O-])C)C)[C@@H]2[C@]1(C)O)C)C(=O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O.[Na+] DGAQECJNVWCQMB-PUAWFVPOSA-M 0.000 claims description 4
- ZLMJMSJWJFRBEC-UHFFFAOYSA-N Potassium Chemical compound [K] ZLMJMSJWJFRBEC-UHFFFAOYSA-N 0.000 claims description 4
- 229910021538 borax Inorganic materials 0.000 claims description 4
- 238000004737 colorimetric analysis Methods 0.000 claims description 4
- OXNIZHLAWKMVMX-UHFFFAOYSA-N picric acid Chemical class OC1=C([N+]([O-])=O)C=C([N+]([O-])=O)C=C1[N+]([O-])=O OXNIZHLAWKMVMX-UHFFFAOYSA-N 0.000 claims description 4
- 229910052700 potassium Inorganic materials 0.000 claims description 4
- 239000011591 potassium Substances 0.000 claims description 4
- 239000011734 sodium Substances 0.000 claims description 4
- 235000010339 sodium tetraborate Nutrition 0.000 claims description 4
- UPUIQOIQVMNQAP-UHFFFAOYSA-M sodium;tetradecyl sulfate Chemical compound [Na+].CCCCCCCCCCCCCCOS([O-])(=O)=O UPUIQOIQVMNQAP-UHFFFAOYSA-M 0.000 claims description 4
- BSVBQGMMJUBVOD-UHFFFAOYSA-N trisodium borate Chemical compound [Na+].[Na+].[Na+].[O-]B([O-])[O-] BSVBQGMMJUBVOD-UHFFFAOYSA-N 0.000 claims description 4
- WHXSMMKQMYFTQS-UHFFFAOYSA-N Lithium Chemical compound [Li] WHXSMMKQMYFTQS-UHFFFAOYSA-N 0.000 claims description 3
- 102000007474 Multiprotein Complexes Human genes 0.000 claims description 3
- 108010085220 Multiprotein Complexes Proteins 0.000 claims description 3
- 239000013060 biological fluid Substances 0.000 claims description 3
- 230000015572 biosynthetic process Effects 0.000 claims description 3
- 150000001875 compounds Chemical class 0.000 claims description 3
- 238000001514 detection method Methods 0.000 claims description 3
- 230000031700 light absorption Effects 0.000 claims description 3
- 229910052744 lithium Inorganic materials 0.000 claims description 3
- 229910052708 sodium Inorganic materials 0.000 claims description 3
- CXPOFJRHCFPDRI-UHFFFAOYSA-N dodecylbenzene;sulfuric acid Chemical compound OS(O)(=O)=O.CCCCCCCCCCCCC1=CC=CC=C1 CXPOFJRHCFPDRI-UHFFFAOYSA-N 0.000 claims description 2
- 229940080236 sodium cetyl sulfate Drugs 0.000 claims description 2
- 229950005425 sodium myristyl sulfate Drugs 0.000 claims description 2
- 229940067741 sodium octyl sulfate Drugs 0.000 claims description 2
- 229910052938 sodium sulfate Inorganic materials 0.000 claims description 2
- 235000011152 sodium sulphate Nutrition 0.000 claims description 2
- 229960000776 sodium tetradecyl sulfate Drugs 0.000 claims description 2
- MWZFQMUXPSUDJQ-KVVVOXFISA-M sodium;[(z)-octadec-9-enyl] sulfate Chemical compound [Na+].CCCCCCCC\C=C/CCCCCCCCOS([O-])(=O)=O MWZFQMUXPSUDJQ-KVVVOXFISA-M 0.000 claims description 2
- HHURSJAUVYNJBT-UHFFFAOYSA-M sodium;heptadecyl sulfate Chemical compound [Na+].CCCCCCCCCCCCCCCCCOS([O-])(=O)=O HHURSJAUVYNJBT-UHFFFAOYSA-M 0.000 claims description 2
- GGHPAKFFUZUEKL-UHFFFAOYSA-M sodium;hexadecyl sulfate Chemical compound [Na+].CCCCCCCCCCCCCCCCOS([O-])(=O)=O GGHPAKFFUZUEKL-UHFFFAOYSA-M 0.000 claims description 2
- NWZBFJYXRGSRGD-UHFFFAOYSA-M sodium;octadecyl sulfate Chemical compound [Na+].CCCCCCCCCCCCCCCCCCOS([O-])(=O)=O NWZBFJYXRGSRGD-UHFFFAOYSA-M 0.000 claims description 2
- WFRKJMRGXGWHBM-UHFFFAOYSA-M sodium;octyl sulfate Chemical compound [Na+].CCCCCCCCOS([O-])(=O)=O WFRKJMRGXGWHBM-UHFFFAOYSA-M 0.000 claims description 2
- HQCFDOOSGDZRII-UHFFFAOYSA-M sodium;tridecyl sulfate Chemical compound [Na+].CCCCCCCCCCCCCOS([O-])(=O)=O HQCFDOOSGDZRII-UHFFFAOYSA-M 0.000 claims description 2
- 239000012086 standard solution Substances 0.000 claims description 2
- 239000008366 buffered solution Substances 0.000 claims 1
- 239000000203 mixture Substances 0.000 claims 1
- OTYBMLCTZGSZBG-UHFFFAOYSA-L potassium sulfate Chemical compound [K+].[K+].[O-]S([O-])(=O)=O OTYBMLCTZGSZBG-UHFFFAOYSA-L 0.000 claims 1
- 210000002966 serum Anatomy 0.000 description 11
- 239000000523 sample Substances 0.000 description 7
- HEMHJVSKTPXQMS-UHFFFAOYSA-M Sodium hydroxide Chemical compound [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 description 6
- 239000000706 filtrate Substances 0.000 description 6
- 235000019333 sodium laurylsulphate Nutrition 0.000 description 6
- 210000002700 urine Anatomy 0.000 description 5
- 238000006243 chemical reaction Methods 0.000 description 4
- CVSVTCORWBXHQV-UHFFFAOYSA-N creatine Chemical compound NC(=[NH2+])N(C)CC([O-])=O CVSVTCORWBXHQV-UHFFFAOYSA-N 0.000 description 4
- 239000012224 working solution Substances 0.000 description 4
- 241000894006 Bacteria Species 0.000 description 3
- WMFOQBRAJBCJND-UHFFFAOYSA-M Lithium hydroxide Chemical compound [Li+].[OH-] WMFOQBRAJBCJND-UHFFFAOYSA-M 0.000 description 3
- 238000012937 correction Methods 0.000 description 3
- 238000011161 development Methods 0.000 description 3
- 230000000694 effects Effects 0.000 description 3
- 238000010828 elution Methods 0.000 description 3
- 238000005259 measurement Methods 0.000 description 3
- 239000000126 substance Substances 0.000 description 3
- 229960003624 creatine Drugs 0.000 description 2
- 239000006046 creatine Substances 0.000 description 2
- 238000011534 incubation Methods 0.000 description 2
- 210000003734 kidney Anatomy 0.000 description 2
- 201000008383 nephritis Diseases 0.000 description 2
- 238000001179 sorption measurement Methods 0.000 description 2
- LWIHDJKSTIGBAC-UHFFFAOYSA-K tripotassium phosphate Chemical compound [K+].[K+].[K+].[O-]P([O-])([O-])=O LWIHDJKSTIGBAC-UHFFFAOYSA-K 0.000 description 2
- NWUYHJFMYQTDRP-UHFFFAOYSA-N 1,2-bis(ethenyl)benzene;1-ethenyl-2-ethylbenzene;styrene Chemical compound C=CC1=CC=CC=C1.CCC1=CC=CC=C1C=C.C=CC1=CC=CC=C1C=C NWUYHJFMYQTDRP-UHFFFAOYSA-N 0.000 description 1
- BTBUEUYNUDRHOZ-UHFFFAOYSA-N Borate Chemical compound [O-]B([O-])[O-] BTBUEUYNUDRHOZ-UHFFFAOYSA-N 0.000 description 1
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 1
- 229910019142 PO4 Inorganic materials 0.000 description 1
- PMZURENOXWZQFD-UHFFFAOYSA-L Sodium Sulfate Chemical compound [Na+].[Na+].[O-]S([O-])(=O)=O PMZURENOXWZQFD-UHFFFAOYSA-L 0.000 description 1
- YKTSYUJCYHOUJP-UHFFFAOYSA-N [O--].[Al+3].[Al+3].[O-][Si]([O-])([O-])[O-] Chemical class [O--].[Al+3].[Al+3].[O-][Si]([O-])([O-])[O-] YKTSYUJCYHOUJP-UHFFFAOYSA-N 0.000 description 1
- 239000002250 absorbent Substances 0.000 description 1
- 230000002745 absorbent Effects 0.000 description 1
- 238000004458 analytical method Methods 0.000 description 1
- 230000005540 biological transmission Effects 0.000 description 1
- 239000012496 blank sample Substances 0.000 description 1
- 210000001124 body fluid Anatomy 0.000 description 1
- 239000010839 body fluid Substances 0.000 description 1
- ZSJHIZJESFFXAU-UHFFFAOYSA-N boric acid;phosphoric acid Chemical compound OB(O)O.OP(O)(O)=O ZSJHIZJESFFXAU-UHFFFAOYSA-N 0.000 description 1
- 239000007853 buffer solution Substances 0.000 description 1
- OZECDDHOAMNMQI-UHFFFAOYSA-H cerium(3+);trisulfate Chemical compound [Ce+3].[Ce+3].[O-]S([O-])(=O)=O.[O-]S([O-])(=O)=O.[O-]S([O-])(=O)=O OZECDDHOAMNMQI-UHFFFAOYSA-H 0.000 description 1
- 238000004040 coloring Methods 0.000 description 1
- 238000012733 comparative method Methods 0.000 description 1
- 230000006378 damage Effects 0.000 description 1
- 238000004925 denaturation Methods 0.000 description 1
- 230000036425 denaturation Effects 0.000 description 1
- 230000006866 deterioration Effects 0.000 description 1
- 201000010099 disease Diseases 0.000 description 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 1
- BNIILDVGGAEEIG-UHFFFAOYSA-L disodium hydrogen phosphate Chemical compound [Na+].[Na+].OP([O-])([O-])=O BNIILDVGGAEEIG-UHFFFAOYSA-L 0.000 description 1
- 238000004090 dissolution Methods 0.000 description 1
- 239000012153 distilled water Substances 0.000 description 1
- 239000012530 fluid Substances 0.000 description 1
- 239000008103 glucose Substances 0.000 description 1
- 208000015181 infectious disease Diseases 0.000 description 1
- 239000003456 ion exchange resin Substances 0.000 description 1
- 229920003303 ion-exchange polymer Polymers 0.000 description 1
- 208000017169 kidney disease Diseases 0.000 description 1
- 229910003002 lithium salt Inorganic materials 0.000 description 1
- 159000000002 lithium salts Chemical class 0.000 description 1
- 230000002503 metabolic effect Effects 0.000 description 1
- 238000012986 modification Methods 0.000 description 1
- 230000004048 modification Effects 0.000 description 1
- NBIIXXVUZAFLBC-UHFFFAOYSA-K phosphate Chemical compound [O-]P([O-])([O-])=O NBIIXXVUZAFLBC-UHFFFAOYSA-K 0.000 description 1
- 239000010452 phosphate Substances 0.000 description 1
- 239000008055 phosphate buffer solution Substances 0.000 description 1
- ONQDVAFWWYYXHM-UHFFFAOYSA-M potassium lauryl sulfate Chemical compound [K+].CCCCCCCCCCCCOS([O-])(=O)=O ONQDVAFWWYYXHM-UHFFFAOYSA-M 0.000 description 1
- 229940116985 potassium lauryl sulfate Drugs 0.000 description 1
- 229910000160 potassium phosphate Inorganic materials 0.000 description 1
- 235000011009 potassium phosphates Nutrition 0.000 description 1
- 239000000047 product Substances 0.000 description 1
- ABPBBOIVOUJALM-UHFFFAOYSA-M sodium;dodecyl sulfate;urea Chemical compound [Na+].NC(N)=O.CCCCCCCCCCCCOS([O-])(=O)=O ABPBBOIVOUJALM-UHFFFAOYSA-M 0.000 description 1
- 238000010186 staining Methods 0.000 description 1
- 239000011550 stock solution Substances 0.000 description 1
- 239000012085 test solution Substances 0.000 description 1
- 208000019553 vascular disease Diseases 0.000 description 1
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Chemical compound O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 1
- 238000004804 winding Methods 0.000 description 1
Classifications
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/70—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving creatine or creatinine
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
- Y10T—TECHNICAL SUBJECTS COVERED BY FORMER US CLASSIFICATION
- Y10T436/00—Chemistry: analytical and immunological testing
- Y10T436/10—Composition for standardization, calibration, simulation, stabilization, preparation or preservation; processes of use in preparation for chemical testing
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
- Y10T—TECHNICAL SUBJECTS COVERED BY FORMER US CLASSIFICATION
- Y10T436/00—Chemistry: analytical and immunological testing
- Y10T436/14—Heterocyclic carbon compound [i.e., O, S, N, Se, Te, as only ring hetero atom]
- Y10T436/145555—Hetero-N
- Y10T436/147777—Plural nitrogen in the same ring [e.g., barbituates, creatinine, etc.]
Landscapes
- Life Sciences & Earth Sciences (AREA)
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Molecular Biology (AREA)
- Biomedical Technology (AREA)
- Chemical & Material Sciences (AREA)
- Hematology (AREA)
- Immunology (AREA)
- Urology & Nephrology (AREA)
- Cell Biology (AREA)
- Microbiology (AREA)
- Biotechnology (AREA)
- Food Science & Technology (AREA)
- Medicinal Chemistry (AREA)
- Physics & Mathematics (AREA)
- Analytical Chemistry (AREA)
- Biochemistry (AREA)
- General Health & Medical Sciences (AREA)
- General Physics & Mathematics (AREA)
- Pathology (AREA)
- Investigating Or Analysing Biological Materials (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US447864A US3894843A (en) | 1974-03-04 | 1974-03-04 | Determination of serum creatinine |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| DE2504994A1 true DE2504994A1 (de) | 1975-09-11 |
Family
ID=23778053
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| DE19752504994 Pending DE2504994A1 (de) | 1974-03-04 | 1975-02-06 | Verfahren zur kreatininbestimmung |
Country Status (12)
Families Citing this family (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4111657A (en) * | 1977-01-21 | 1978-09-05 | American Monitor Corporation | Creatinine assay and reagent system |
| US4529708A (en) * | 1983-04-07 | 1985-07-16 | American Monitor Corporation | Assay for the determination of creatinine |
| US4539295A (en) * | 1983-06-30 | 1985-09-03 | Beckman Instruments, Inc. | Binary kinetic assay method and apparatus |
| US4818703A (en) * | 1985-10-23 | 1989-04-04 | Pizzolante John M | Stabilized alkaline picrate reagent for jaffe creatinine determination |
| US4950611A (en) * | 1987-06-26 | 1990-08-21 | Beckman Instruments | Cold stable liquid creatinine reagent |
| CN101466875B (zh) * | 2006-06-12 | 2011-01-05 | 日矿金属株式会社 | 具有粗化处理面的轧制铜或铜合金箔以及该轧制铜或铜合金箔的粗化方法 |
| KR102205101B1 (ko) | 2014-02-28 | 2021-01-19 | 닛토덴코 가부시키가이샤 | 소변 검사 장치 및 정량적 소변 검사를 위한 건식 시약 |
Family Cites Families (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE1648977A1 (de) * | 1967-07-20 | 1970-08-13 | Merck Anlagen Gmbh | Farbreagenz zur Bestimmung von Kreatinin |
| US3705013A (en) * | 1970-01-05 | 1972-12-05 | Xerox Corp | Analytical procedures and compositions therefor |
| US3682586A (en) * | 1971-03-10 | 1972-08-08 | Union Carbide Corp | Process for the determination of creatinine body fluids |
-
1974
- 1974-03-04 US US447864A patent/US3894843A/en not_active Expired - Lifetime
- 1974-12-18 NL NL7416476A patent/NL7416476A/xx unknown
- 1974-12-25 IL IL46338A patent/IL46338A/en unknown
-
1975
- 1975-01-08 BE BE6044885A patent/BE824205A/xx unknown
- 1975-01-13 ZA ZA00750224A patent/ZA75224B/xx unknown
- 1975-01-24 GB GB321475A patent/GB1445954A/en not_active Expired
- 1975-01-24 ES ES434127A patent/ES434127A1/es not_active Expired
- 1975-01-30 SE SE7501016A patent/SE7501016L/xx unknown
- 1975-01-30 FR FR7502948A patent/FR2263515A1/fr not_active Withdrawn
- 1975-01-31 JP JP50012630A patent/JPS50120897A/ja active Pending
- 1975-01-31 CH CH127875A patent/CH594245A5/xx not_active IP Right Cessation
- 1975-02-06 DE DE19752504994 patent/DE2504994A1/de active Pending
Also Published As
| Publication number | Publication date |
|---|---|
| ES434127A1 (es) | 1977-03-01 |
| US3894843A (en) | 1975-07-15 |
| AU7596374A (en) | 1976-06-03 |
| IL46338A0 (en) | 1975-03-13 |
| SE7501016L (enrdf_load_stackoverflow) | 1975-09-05 |
| BE824205A (nl) | 1975-07-08 |
| IL46338A (en) | 1977-10-31 |
| ZA75224B (en) | 1976-08-25 |
| CH594245A5 (enrdf_load_stackoverflow) | 1977-12-30 |
| FR2263515A1 (enrdf_load_stackoverflow) | 1975-10-03 |
| NL7416476A (nl) | 1975-09-08 |
| JPS50120897A (enrdf_load_stackoverflow) | 1975-09-22 |
| GB1445954A (en) | 1976-08-11 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| DE1944246A1 (de) | Verfahren und Vorrichtung zur quantitativen Bestimmung von chemischen Blutsubstanzen in Blutderivaten | |
| DE1240306B (de) | Mittel zum Nachweis von Harnstoff im Blut | |
| DE69119410T2 (de) | Reagenz und verfahren zur kalziumbestimmung | |
| DE2725961A1 (de) | Reagens fuer untersuchung auf protein und verfahren zur untersuchung auf protein | |
| DD247808A3 (de) | Teststreifen zur aufnahme von blutzuckertagesprofilen und verfahren zu seiner herstellung | |
| EP0203334A2 (de) | Mittel und Verfahren zur Bestimmung von Calcium | |
| DE2504994A1 (de) | Verfahren zur kreatininbestimmung | |
| DE69026611T2 (de) | Verfahren zur Bestimmung von Fruktosaminen | |
| EP0664454B1 (de) | Verfahren und Reagenz zur Bestimmung von Eisen | |
| DE2751904C2 (de) | Verfahren und Mittel zur Bestimmung von Kreatinin in biologischen Flüssigkeiten | |
| DE2530036B2 (de) | Verfahren zur Bestimmung von Harnstoff in Flüssigkeiten | |
| DE2335350C2 (de) | Bestimmung von Calcium | |
| DE2759962C2 (de) | Verfahren zur quantitativen Bestimmung von Harnstoff | |
| EP0351605B1 (de) | Quantitative Bestimmung von Phosphor | |
| EP1119641B1 (de) | Verfahren zur bestimmung von alkalischer phosphatase unter beseitigung von hämoglobin-störungen | |
| EP0340511A1 (de) | Trägergebundenes mehrkomponentiges Nachweissystem zur kolorimetrischen Bestimmung esterolytisch oder/und proteolytisch aktiver Inhaltsstoffe von Körperflüssigkeiten | |
| DE1648977A1 (de) | Farbreagenz zur Bestimmung von Kreatinin | |
| DE69111016T2 (de) | Zusammensetzung von Agenzien zum Nachweis einer Redox-Reaktion. | |
| DE2225275A1 (de) | Verfahren zur quantitativen Calciumbestimmung | |
| DE60012707T2 (de) | Entstörungsmembranen, Teststreifen, Kits und Verfahren zum Harnsäure-Assay | |
| DD249974A1 (de) | Verfahren zur bestimmung des protein- und des fettgehaltes, insbesondere von milch | |
| DE68915838T2 (de) | Kalziumtestreagenz. | |
| DE3817907A1 (de) | Verfahren und reagenz zur bestimmung von eisen | |
| DE4446698C2 (de) | Mikrotiterplatte mit einem Mittel zur Anzeige des Befüllungszustandes, Herstellung einer Mikrotiterplatte und Verwendung eines pH-Indikators | |
| DE19742117A1 (de) | Verfahren zur Messung von Harnstoffstickstoff und Untersuchungssets dafür |